Terms: = Thyroid cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Treatment
88 results:
1. Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with
Oh Y; Park JH; Djunadi TA; Shah Z; Chung LI; Chae YK
Front Endocrinol (Lausanne); 2024; 15():1304188. PubMed ID: 38356955
[TBL] [Abstract] [Full Text] [Related]
2. thyroid dysfunction caused by exposure to environmental endocrine disruptors and the underlying mechanism: A review.
He J; Xu J; Zheng M; Pan K; Yang L; Ma L; Wang C; Yu J
Chem Biol Interact; 2024 Mar; 391():110909. PubMed ID: 38340975
[TBL] [Abstract] [Full Text] [Related]
3. USP10 suppresses ABCG2-induced malignant characteristics of doxorubicin-resistant thyroid cancer by inhibiting PI3K/AKT pathway.
Sun J; Xiang Q; Ding D; Yan N
J Bioenerg Biomembr; 2023 Dec; 55(6):457-466. PubMed ID: 37919637
[TBL] [Abstract] [Full Text] [Related]
4. Anaplastic thyroid cancer:Improved understanding of what remains a deadly disease.
Cleere EF; Prunty S; O'Neill JP
Surgeon; 2024 Feb; 22(1):e48-e53. PubMed ID: 37866980
[TBL] [Abstract] [Full Text] [Related]
5. TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer.
Gou H; Wong CC; Chen H; Shang H; Su H; Zhai J; Liu W; Liu W; Sun D; Wang X; Yu J
Cancer Lett; 2023 Dec; 578():216438. PubMed ID: 37827326
[TBL] [Abstract] [Full Text] [Related]
6. The impact of PIK3CA mutations and pten expression on the effect of neoadjuvant therapy for postmenopausal luminal breast cancer patients.
Hayama S; Nakamura R; Ishige T; Sangai T; Sakakibara M; Fujimoto H; Ishigami E; Masuda T; Nakagawa A; Teranaka R; Ota S; Itoga S; Yamamoto N; Nagashima T; Otsuka M
BMC Cancer; 2023 Apr; 23(1):384. PubMed ID: 37106324
[TBL] [Abstract] [Full Text] [Related]
7. Targeting the E3 ligase NEDD4 as a novel therapeutic strategy for IGF1 signal pathway-driven gastric cancer.
Wang K; Yu Y; Wang W; Jiang Y; Li Y; Jiang X; Qiao Y; Chen L; Zhao X; Liu J; Yang A; Li J; Zhang R
Oncogene; 2023 Mar; 42(14):1072-1087. PubMed ID: 36774408
[TBL] [Abstract] [Full Text] [Related]
8. PICT-1 regulates p53 splicing and sensitivity of medullary thyroid carcinoma cells to everolimus.
Bareli Y; Shimon I; Tobar A; Rubinfeld H
J Neuroendocrinol; 2022 Oct; 34(10):e13187. PubMed ID: 36306198
[TBL] [Abstract] [Full Text] [Related]
9. Long-term treatment of cancer-prone germline pten mutant mice with low-dose rapamycin extends lifespan and delays tumour development.
Tibarewal P; Rathbone V; Constantinou G; Pearce W; Adil M; Varyova Z; Folkes L; Hampson A; Classen GAE; Alves A; Carvalho S; Scudamore CL; Vanhaesebroeck B
J Pathol; 2022 Dec; 258(4):382-394. PubMed ID: 36073856
[TBL] [Abstract] [Full Text] [Related]
10. thyroid Follicular Cell-derived Carcinomas in a Background of Multiple Adenomatous Nodules Leading to a Diagnosis of
Liu A; Borges PM; Tay YS; Thompson LDR; Kong MX; Lai J
Anticancer Res; 2022 Mar; 42(3):1481-1485. PubMed ID: 35220242
[TBL] [Abstract] [Full Text] [Related]
11. Comparative and mechanistic study of pharmacodynamic difference in anti-breast cancer activity between water and liquor extracts of Xiaojin Pills.
Liu H; Cao B; Li C; Han L; Xu H; Lin J; Zhang D; Xu R
J Ethnopharmacol; 2022 Jun; 291():115104. PubMed ID: 35218896
[TBL] [Abstract] [Full Text] [Related]
12. The Association of the BRAF-V600E Mutation with the Expression of the Molecular Markers in the Primary Tumor and Metastatic Tissue in Papillary thyroid cancer.
Spirina LV; Chizhevskaya SY; Kovaleva IV; Kondakova IV
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2017-2024. PubMed ID: 34319022
[TBL] [Abstract] [Full Text] [Related]
13. The INPP4B paradox: Like pten, but different.
Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
[TBL] [Abstract] [Full Text] [Related]
14. Joint Detection of Tap and CEA Based on Deep Learning Medical Image Segmentation: Risk Prediction of thyroid cancer.
Lang S; Xu Y; Li L; Wang B; Yang Y; Xue Y; Shi K
J Healthc Eng; 2021; 2021():5920035. PubMed ID: 34158913
[TBL] [Abstract] [Full Text] [Related]
15. The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer.
Gao PP; Qi XW; Sun N; Sun YY; Zhang Y; Tan XN; Ding J; Han F; Zhang Y
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188562. PubMed ID: 33964330
[TBL] [Abstract] [Full Text] [Related]
16. Anaplastic thyroid Carcinoma: Current Issues in Genomics and Therapeutics.
Abe I; Lam AK
Curr Oncol Rep; 2021 Feb; 23(3):31. PubMed ID: 33582932
[TBL] [Abstract] [Full Text] [Related]
17. Upregulation of DJ-1 expression in melanoma regulates pten/AKT pathway for cell survival and migration.
Lee YJ; Kim WI; Park TH; Bae JH; Nam HS; Cho SW; Choi YJ; Lee SH; Cho MK
Arch Dermatol Res; 2021 Sep; 313(7):583-591. PubMed ID: 32959108
[TBL] [Abstract] [Full Text] [Related]
18. Effects of metformin and pioglitazone combination on apoptosis and AMPK/mTOR signaling pathway in human anaplastic thyroid cancer cells.
Ozdemir Kutbay N; Biray Avci C; Sarer Yurekli B; Caliskan Kurt C; Shademan B; Gunduz C; Erdogan M
J Biochem Mol Toxicol; 2020 Oct; 34(10):e22547. PubMed ID: 32589349
[TBL] [Abstract] [Full Text] [Related]
19. Regulators of glucose uptake in thyroid cancer cell lines.
Heydarzadeh S; Moshtaghie AA; Daneshpoor M; Hedayati M
Cell Commun Signal; 2020 Jun; 18(1):83. PubMed ID: 32493394
[TBL] [Abstract] [Full Text] [Related]
20. Cowden syndrome complicated by schizophrenia: A first clinical report.
Kobayashi Y; Takeda T; Kunitomi H; Ueki A; Misu K; Kowashi A; Takahashi T; Anko M; Watanabe K; Masuda K; Uchida T; Tominaga E; Banno K; Kosaki K; Aoki D
Eur J Med Genet; 2020 Aug; 63(8):103959. PubMed ID: 32461083
[TBL] [Abstract] [Full Text] [Related]
[Next]
